Skip to main content
GaldermaLinkedIn

Galderma reports synergistic benefits of Sculptra and Restylane for medication-driven weight loss patients.

Source

LinkedInJul 28, 2026
likes
259
comments
7

Post

A new publication in Clinical, Cosmetic and Investigational Dermatology reinforces the synergistic benefits of Sculptra® and Restylane® in addressing facial sagging and volume loss associated with medication-driven weight loss. The case series report, led by Dr. Luiz Avelar and supported by Galderma, collected real-world data based on the report’s authors’ clinical practices across Latin America in patients of different ages and ethnicities showing the ability of these treatments to meet diverse aesthetic needs. These results highlight Galderma’s commitment to advancing science and knowledge around the treatment of aesthetic changes associated with medication-driven weight loss. Find out more: https://lnkd.in/eapXqfXB Always consult a healthcare professional for individualized treatment recommendations and to discuss important safety information and risks associated with the use of the products. #AdvancingDermatology #SkinScienceByGalderma

linkedin.com/posts/galderma-_advancingdermatology-skinsciencebygalder...Read the full source

Extracted by Autobound

From the Signal API record
Signal
LinkedIn

What this signalsCompany posts often show what the team is pushing right now.

The full record

From the Signal API record

Topics and mentions

Tags

  • Medical Research
  • Pharmaceuticals
  • Product Development

Initiatives

  • advancing science in aesthetic treatment for weight loss patients

Technologies named

  • Sculptra
  • Restylane

Extraction

Detected
Aug 13, 2026
signal_type
linkedin-post-company
signal_subtype
linkedinPost

Use this data

Get every LinkedIn signal for Galderma and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Galderma this week?”

  2. Send it to your own tools

    The Signal API returns LinkedIn signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full linkedin-post-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/1955976c-1612-4dd5-9987-e93aa3bcf33b returns this record as JSON. POST /v1/companies/enrich returns every signal for galderma.com.

{
  "signal_id": "1955976c-1612-4dd5-9987-e93aa3bcf33b",
  "signal_type": "linkedin-post-company",
  "signal_subtype": "linkedinPost",
  "detected_at": "2026-08-13T10:39:10.995+00:00",
  "company": {
    "name": "Galderma",
    "domain": "galderma.com"
  },
  "data": {
    "tags": [
      "Medical Research",
      "Pharmaceuticals",
      "Product Development"
    ],
    "summary": "Galderma reports synergistic benefits of Sculptra and Restylane for medication-driven weight loss patients.",
    "post_url": "https://www.linkedin.com/posts/galderma-_advancingdermatology-skinsciencebygalderma-activity-7487882360240295937-N5J-",
    "num_likes": 259,
    "post_text": "A new publication in Clinical, Cosmetic and Investigational Dermatology reinforces the synergistic benefits of Sculptra® and Restylane® in addressing facial sagging and volume loss associated with medication-driven weight loss. \n\nThe case series report, led by Dr. Luiz Avelar and supported by Galderma, collected real-world data based on the report’s authors’ clinical practices across Latin America in patients of different ages and ethnicities showing the ability of these treatments to meet diverse aesthetic needs. \n\nThese results highlight Galderma’s commitment to advancing science and knowledge around the treatment of aesthetic changes associated with medication-driven weight loss.\n\nFind out more: https://lnkd.in/eapXqfXB\n\nAlways consult a healthcare professional for individualized treatment recommendations and to discuss important safety information and risks associated with the use of the products.  \n\n#AdvancingDermatology \n#SkinScienceByGalderma",
    "initiatives": [
      {
        "topic": "advancing science in aesthetic treatment for weight loss patients",
        "urgency": 0.6
      }
    ],
    "posted_date": "2026-07-28T14:51:12.808Z",
    "num_comments": 7,
    "technologies_mentioned": [
      {
        "name": "Sculptra",
        "status": "using"
      },
      {
        "name": "Restylane",
        "status": "using"
      }
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.